Results 191 to 200 of about 33,580 (237)

Anti‐PEG Antibodies From mRNA COVID‐19 Vaccines Affect In Vitro Measurements of Pegylated Drug Levels

open access: yesClinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT The recent adoption of mRNA‐based technology for vaccine development has led to widespread exposure to new vaccine components, such as polyethylene glycol (PEG), against which antibodies may be made. This study assesses the presence of anti‐PEG antibodies in human serum following SARS‐CoV‐2 vaccination, and if these antibodies could interfere ...
Elizaveta A. Svyatova   +8 more
wiley   +1 more source

Population Pharmacokinetics of Rituximab in Treatment‐Naïve Chinese Patients With Diffuse Large B‐cell Lymphoma During Induction Therapy: Clinical Implications

open access: yesClinical and Translational Science, Volume 19, Issue 8, August 2026.
A schematic summary of the population pharmacokinetic model of rituximab in treatment‐naïve Chinese DLBCL patients during induction therapy, along with key clinical implications. ABSTRACT This study aimed to establish and validate a population pharmacokinetic model for rituximab during induction therapy in treatment‐naive patients with diffuse large B ...
Wan‐Yi Zhou   +5 more
wiley   +1 more source

Development and Evaluation of Multiple-Unit Tablets for the Controlled Release of Lornoxicam. [PDF]

open access: yesDrugs R D
Liu Y   +7 more
europepmc   +1 more source

Evaluation of the local tolerance and systemic safety of a novel intravaginal probiotic product in cows. [PDF]

open access: yesVet Res Commun
Csikó G   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy